Advances in reprogramming somatic cells to induced pluripotent stem cells.
about
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade statusInduced Pluripotent Stem Cell as a New Source for Cancer ImmunotherapyCurrent status of induced pluripotent stem cells in cardiac tissue regeneration and engineeringCell fusion in the brain: two cells forward, one cell back.Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseaseEfficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compoundsHigh-efficient generation of induced pluripotent stem cells from human astrocytesInduced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.C/EBPδ gene targets in human keratinocytes.Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.Cellular reprogramming for understanding and treating human disease.FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cellsModeling stem cell induction processes.Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system.Extensive modulation of the transcription factor transcriptome during somatic embryogenesis in Arabidopsis thalianaCryopreservation of Human Stem Cells for Clinical Application: A ReviewRegenerative Medicine for the Aging Brain.Elevated in vivo levels of a single transcription factor directly convert satellite glia into oligodendrocyte-like cellsA widely adaptable approach to generate integration-free iPSCs from non-invasively acquired human somatic cells.Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors.Transdifferentiation of Fibroblasts by Defined Factors.Effect of NELL1 gene overexpression in iPSC-MSCs seeded on calcium phosphate cement.CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB PathwayRadiation-induced reprogramming of breast cancer cells.TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stabilityModulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.Characterization of the stem cell niche and its importance in radiobiological response.MEF promotes stemness in the pathogenesis of gliomas.The tumourigenicity of iPS cells and their differentiated derivates.FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived hiPSCs and Aging Motoneurons.Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.Genome resource banking of biomedically important laboratory animals.EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α.MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.Gene therapy for β-thalassaemia: the continuing challenge.Tinkering with transcription factors uncovers plasticity of somatic cellsTurning skin into dopamine neurons.
P2860
Q21999273-32C5F3F3-84E3-40B8-B2E1-FB83143ADBDEQ26750579-D450DF0F-6BC4-44FB-B2DF-303D6BBD26E8Q26863381-1992F1D0-61E3-4B1A-8E13-AC93D6002FFFQ27691973-A8A2F4FD-35B1-40F6-AA39-200FC7C1FF4CQ28080770-5C0A57DF-DC0F-449C-90E4-B05B879E8C4AQ28477627-08DB6425-B88B-4149-82C4-315D9ED415CFQ28744346-DFC8E48C-CDB9-4500-B9B5-2732D0B8AA9DQ30531604-9029F3AD-9365-4E8A-BFB6-ABB87EE2F321Q33745060-06CB565D-19AB-4916-8727-1F7085D24E41Q33793268-AF020AE8-4398-4DDE-A329-E6D6F5241A06Q33975595-B4CACCD4-0857-4AA0-BE74-EA447E72100CQ34232257-1FA9C1F9-7898-411E-8A73-617857A4F50DQ34496408-077621AE-6778-4F6D-8884-E0F439CC7196Q34619436-AC63A5C5-9AA3-449E-8406-A35CBB3DCB81Q34716786-3B8F63E3-7550-4800-845C-ED26726EAF1BQ34731906-B942E995-84EC-480D-8336-EFBF6E0274FCQ34853600-847E0949-93EA-4770-8021-20860A259147Q34939259-A8140CCB-3C1A-413C-96E5-6582785E11D9Q35089532-DFC7080D-E69F-4208-A718-2433F7C0EC57Q35561135-70AF3814-13F1-467A-918A-DB9BDE593C3AQ35563718-58638245-4389-43BC-8315-4FD3FFFF9AC5Q35790043-5D7E63DE-D6A0-4382-A776-C3D8FA545321Q35805656-35B2237A-1985-4779-8131-7F5D338B9764Q36024593-7191D5F1-4247-4A56-BE54-E45E62D0A12FQ36098901-3725FE5A-E669-41BF-A8AA-5C5A5391DC02Q36145678-93359DF4-3B27-4C99-83B6-0DD3349DAC0FQ36273603-BFF8E5CE-063F-45C3-AF4B-F56E82F69BDDQ36335774-7F0D3E2C-B59E-4AAB-94D9-489178A6265AQ36441932-8BDF0F5F-87EA-4685-A415-2025419AB24EQ37158304-74C6CEA8-C85A-43F9-9B5A-5FAD376B493FQ37267797-0CAC6C50-F291-4925-B950-B6C0B14F746DQ37295432-8DD11D66-4CA0-419F-B3A7-9D1CF72582E8Q37531676-5D7B5705-067C-42A8-9F11-F3104B1170D1Q37561102-DE71744E-D2D7-4BD7-91A8-01980179F1A2Q37612445-3BC3923A-ECE1-4D6E-8C00-9CA189362BF3Q37623510-DF1EB88A-A611-4015-A4E2-D5692D8F80EFQ37706915-B08C0BB0-FD34-4716-9263-95F9290093A2Q37795125-773B5E3A-7A27-4C69-BC93-C6E9983B73F1Q37903690-F2CA4168-9DBA-4AB5-9DC8-88B3988E6333Q37913998-E61DA3D5-52B4-45A6-8314-12CEC264C291
P2860
Advances in reprogramming somatic cells to induced pluripotent stem cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@en
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@nl
type
label
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@en
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@nl
prefLabel
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@en
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@nl
P2860
P1476
Advances in reprogramming somatic cells to induced pluripotent stem cells.
@en
P2093
Minal Patel
Shuying Yang
P2860
P2888
P304
P356
10.1007/S12015-010-9123-8
P577
2010-09-01T00:00:00Z
P5875
P6179
1029512333